packageDarinaparsin

darinaparsin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Darinaparsin is an investigational antineoplastic agent, an arsenic-based compound studied for cancer treatment. It is not an approved medicine; it remains under investigation and is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q27166111 and the WHO ATC classification; not checked by a person.

name:darinaparsin
ATC codes:L01XX82
DrugBank:DB06179
PubChem CID:11683005
ChEBI:94295
Wikidata:Q27166111
formula:C12H22AsN3O6S
molar mass:411.305 g/mol (PubChem CID 11683005)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown